NDC 0832-0038-89 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0832-0038
- Requested NDC
- 0832-0038-89
- Package NDCs from labels
- 0832-0038-00, 0832-0038-50, 0832-0038-10, 0832-0038-89, 0832-0038-01
- Manufacturer
- Upsher-Smith Laboratories, LLC | Bora Pharmaceuticals, Inc
- Effective date
- 2025-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - Upsher-Smith Laboratories, LLC | Bora Pharmaceuticals, Inc | Upsher-Smith Laboratories, LLC | Bora Pharmaceuticals, Inc | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - RedPharm Drug, Inc. | RedPharm Drug, Inc. | 2022-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride Tablets, USP | REMEDYREPACK INC. | 2019-12-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride Tablets, USP | REMEDYREPACK INC. | 2019-08-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals | Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals | 2018-08-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - A-S Medication Solutions | A-S Medication Solutions | 2017-09-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2016-06-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2013-09-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0832-0038-00 | Oxybutynin Chloride | 100 in 1 BOTTLE | TABLET | 100 | 17 | |
| 0832-0038-01 | Oxybutynin Chloride | 100 in 1 CARTON | TABLET | 100 | 17 | |
| 0832-0038-10 | Oxybutynin Chloride | 1000 in 1 BOTTLE | TABLET | 1000 | 17 | |
| 0832-0038-50 | Oxybutynin Chloride | 500 in 1 BOTTLE | TABLET | 500 | 17 | |
| 0832-0038-89 | Oxybutynin Chloride | 1 in 1 BLISTER PACK | TABLET | 1 | 17 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0832-0038-00 | EA - Each | 0832-0038 | f3763031-4e45-4646-a8ba-3d7de1546c35 | 1 | 2012-07-24 |
| 0832-0038-01 | EA - Each | 0832-0038 | 1d2f3647-37a1-426a-948e-97432f95886d | 1 | 2018-06-11 |
| 0832-0038-10 | EA - Each | 0832-0038 | 177cafb0-d308-4e31-89b9-4595cb6ea70e | 1 | 2012-07-24 |
| 0832-0038-50 | EA - Each | 0832-0038 | 45fb36e1-d85b-47fb-970b-be7fd4528abb | 1 | 2012-07-24 |
| 0832-0038-89 | EA - Each | 0832-0038 | ebc21517-3bb5-4b5e-a6ad-415af411acff | 1 | 2018-06-11 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 7593becc-250f-4d25-8401-a9f72f3f5ad4 | 2024-06-03 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 8f147f73-cfc6-40a3-b1a3-e4cab1868523 | 2024-06-03 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 39a2d144-0c10-4aec-9fa4-0adc24b332eb | 2024-06-03 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 169d6d58-8887-4bdd-95bd-873d1f049eaa | 2024-05-24 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Proficient Rx LP | 7d2332b4-9e48-4bb2-a2c3-75e16e1d455b | 2024-04-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 2f898b29-46cf-4427-bb64-8c30532222f5 | 2024-01-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 5e3b454b-6d3c-418b-8ac2-b0e17f018bbf | 2023-12-27 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | afc6a3aa-e43d-4f10-bdbd-570a149bf9db | 2023-12-27 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | Zydus Pharmaceuticals USA Inc. | c042bf06-79a3-4dc7-ae05-3ef3cfae9d44 | 2023-11-07 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 83522acd-0ecc-46ac-a018-a3205ba096ff | 2023-11-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 5b72d34e-ae57-4459-ba2c-3bae8a69c5c1 | 2023-10-04 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 02ff3be7-fc5c-4b91-8c67-ecdf6e19c42a | 2023-05-31 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d2bb6927-5fbf-49ca-a891-d701bff1c812 | 2023-05-31 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Lannett Company, Inc. | c5950dba-d92b-46a0-993f-af9f9ddb52bf | 2023-05-30 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | A-S Medication Solutions | 1f95920c-5dc2-44e4-b61d-b2c5e05390ba | 2023-02-06 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Amneal Pharmaceuticals LLC | 53924eba-1919-4203-9a1e-d57dfdd3b963 | 2023-02-02 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 1e1c1043-e4c5-4a06-9cc1-45d4397746f4 | 2023-01-04 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Proficient Rx LP | e3f0c249-8085-4979-823a-820e233a284f | 2022-06-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Proficient Rx LP | 88f08450-559e-4038-aad1-051e4ab283cf | 2022-06-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Leading Pharma, LLC | b73b8338-8045-448f-87a6-3d289227d00e | 2022-02-14 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.